1. Changping Deng, Jiacheng Ma, Yuping Liu, Xikui Tong, Lei Wang, Jiayi Dong, Ping Shi, Meiyan Wang, Wenyun Zheng*, Xingyuan Ma*. Targeting intracellular cancer proteins with tumor-microenvironment-responsive bispecific nanobody-PROTACs for enhanced therapeutic efficacy. MedComm. 2025 ;6(2): e70068.

2. Yunhui Fu, Yiwen Zhou, Yiying Chen, Zhedan Zhang, Chen Zhang, Changping Deng, Xikui Tong, Wenyun Zheng*锛�Meiyan Wang* and Xingyuan M*. Development of ZmT-PEG hydrogels through Michael addition reaction and protein self-assembly for 3D cell culture.Biomaterial Science, 2024, 12, 5803-5811   

3. Lei Wang, Jiayi Dong, Chenglu Wu, Chengyue Yan, Chong Bi, Chengnan Xu, Yilin Wu, WenyunZheng* and Xingyuan Ma*. Development of a synthetic library of humanized nanobodies for targeted IL-6 inhibition.Frontiers in Bioengineering and Biotechnology, 2024,12: 1440150.

4. Changping Deng, Shihui Li, Yuping Liu, Wen Bao, Chengnan Xu, Wenyun Zheng*, Meiyan Wang, Xingyuan Ma*. Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras ontogenetically coordinated regulation of Survivin to control the fate of cancer cells. Clinical and Translational Medicine. 2023, 13(8): e1382.   

5. Hui Miao, Chang Liu, Hao Ouyang, Peiwen Zhang, Yuping Liu, Chen Zhang, Changping Deng, Yunhui Fu, Jinping Niu, Wenyun Zheng*, Fang You, Yi Yang* and Xingyuan Ma*. A nanobody-based molecular toolkit for ubiquitin-proteasome system explores the main role of survivin subcellular localization. Frontiers in Bioengineering and Biotechnology, 2023, 10.3389  

6. Fabiao Hu, Changping Deng, Yiwen Zhou, Yuping Liu, Tong Zhang, Peiwen Zhang, Zhangting Zhao, Hui Miao, Wenyun Zheng*, Wenliang Zhang, Meiyan Wang*, Xingyuan Ma*, Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment-mediated protein nanocages for enhancing cancer biotherapy,Bioengineering & Translational Medicine, 2022; 7(2): e10290.

7. Changping Deng, Fabiao Hu, Zhangting Zhao, Yiwen Zhou, Yuping Liu, Tong Zhang, Shihui Li, Wenyun Zheng*, Wenliang Zhang, Tianwen Wang*, Xingyuan Ma*. The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-glycoprotein in Cancer Multi-drug Resistance, Frontiers in Cell and Developmental Biology, 2021,10.3389.

8. Wei Guo, Xingyuan Ma, Yunhui Fu, Chang Liu, Qiuli Liu, Fabiao Hu, Hui Miao, Tong Zhang, Yuping Liu, Myong Hun Han, Fang You, Yi Yang* and Wenyun Zheng*. Discovering and characterizing of survivin dominant negative mutants with stronger pro-apoptotic activity on cancer cells and CSCs. Frontiers in Oncology. 2021, 11:635233.

9. Jifan Nie, Xingyuan Ma, Fabiao Hu, Hui Miao, Peiwen Zhang, Myong Hun Han, Fang You, YiYang, WenyunZheng*. Designing and constructing a phage display synthesized single domain antibodies library based on camel VHH frame for  screening and identifying humanized TNF-伪-specific nanobody锛�Biomedicine & Pharmacotherapy, 2021, DOI: 10.1016/j.biopha.2021.111328

10. Zhangting Zhao, Xingyuan Ma, Ruihuan Zhang, Fabiao Hu, Tong Zhang, Yuping Liu, Myong Hun Han, Fang You, Yi Yang^鈦�, Wenyun Zheng*. A novel liposome-polymer hybrid nanoparticles delivering a multi-epitope 2 self-replication DNA vaccine and its preliminary immune evaluation in 3 experimental animals. Nanomedicine: Nanotechnology, Biology, and Medicine. 2021, (35): 102338.

11. Lingke Liu, Xiaoxiao Chen, Ruilin Gao, Kejian Wang, Wenyun Zheng^鈭�, Haipeng Liu^鈭�. A cytokine receptor domeless promotes white spot syndrome virus infection via JAK/STAT signaling pathway in red claw crayfish Cherax quadricarinatus. Developmental and Comparative Immunology, 2020, 111: 103749.

12. Fabiao Hu, Ruihuan Zhang, Wei Guo, Ting Yan, Xiujuan He, Fengzhi Hu, Fuzheng Ren, Xingyuan Ma*, Jiandu Lei, Wenyun Zheng*. PEGylated-PLGA Nanoparticles Coated With pH Responsive Tannic acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer锛�Molecular Pharmaceutics. 2021, 18(6):2161-2173.

13. Fabiao Hu,Ting Yan, Wei Guo, Qiuli Liu, Myong Hun Han, Chang Liu,Yuping Liu, Wenyun Zheng*, Fang You*, Yi Yang, Wenliang Zhang and Xingyuan Ma*. Multiple targeting strategies achieve novel protein drug deliver into cancer cells to proapoptosis lung cancer cell by precisely inhibiting surviving. Nanoscale. 2020, 12,10623-10638.

14. Wenpeng Wang#, Wenyun Zheng#, Fengzhi Hu, Xiujuan He, Dong Wu, Wenliang Zhang, Haipeng Liu锛�and Xingyuan Ma*. Enhanced Biosynthesis Performance of Heterologous Proteins in CHO-K1 Cells Using CRISPR-Cas9. ACS Synth. Biol. 2018, 7, 1259-1268.

15. Chen XX, Li YY, Chang XJ, Xie XL, Liang YT, Wang KJ, Zheng WY*, Liu HP*. A CqFerritin protein inhibits white spot syndrome virus infection via regulating iron ions in red claw crayfish Cherax quadricarinatus. Dev Comp Immunol.2018; 82:104-112.  

16. Fabiao Hu, Daxia Pan, Wenyun Zheng*, Xiujuan He, Fuzheng Ren, Yiming Lu, Xingyuan Ma.Elucidating respective functions of two domains BIR and CHelix of human IAP survivin for precise targeted regulating mitotic cycleapoptosis and autophagy of cancer cells. Oncotarget. 2017,8(69):113687-113700.

17. Di Liu, Fabiao Hu, Wenpeng Wang, Dong Wu, Xiujuan He, Wenyun Zheng*, Haipeng Liu*, Xingyuan Ma*. Elucidating bottlenecks of the efficient preparation of an AB5hexamer mucosal adjuvant protein LTm by genetic engineering. Journal of Microbiology and Biotechnology. 2017, 27(8):1461-147.

18. Xingyuan Ma, Yi Zhang, Yanyan Kang, Linfeng Li, Wenyun Zheng*. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells (BCSCs) by down-regulating the expression of Cyclin D1. Biomedicine & Pharmacotherapy, 2016, 23(84):373-381

19. Xingyuan Ma, Nanjing Lin, Yanyan Kang, Linfeng Li, Wenyun Zheng*, Screening and identification of highly specific McAbs for discovering novel biomarkers of bone marrow stromal cells, Monoclonal Antibody in immunodiagnosis and immunotherapy, 2016, 35(4): 199-211.

20. Liqun Wang, Yanyan Kang, Wenyun Zheng*, Linfeng Li, Lei Shi, Xingyuan Ma. Effect on apoptosis and cell cycle of recombinant double negative dominant mutation Survivin (T34/117A) in breast cancer cell B-Cap-37. Biomedicine & Pharmacotherapy, 2014, 68(3): 277鈥�284

21. Nanjing Lin^#, Wenyun Zheng^#, Linfeng Li, Hui Liu, Tianwen Wang, Ping Wang, Xingyuan Ma*. A novel system enhancing the endosomal escapes of peptides promotes Bak BH3 peptide inducing apoptosis in lung cancer A549 cells.Targeted Oncology. 2014, 9(2): 163-170.

22. Wenyun Zheng, Wenyao Zhang, Wei Hu, and Yi Yang锛�Exploring the Smallest Active Fragment of HsQSOX1b and Discovery of a Highly Efficient Oxidative Engine,PLoS One. 2012,7 (7): e40935. doi:10.1371.

23. Yuxin Xu^#, Wenyun Zheng^#, Tianwen Wang, Ping Wang, Ling Zhu, Xingyuan Ma*. Genetic protein TmSm(T34A) enhances sensitivity of chemotherapy to breast cancer cell lines as a synergistic drug to doxorubicin. Biomedicine & Pharmacotherapy, 2012, 66(5): 368-372.

24. Wenyun Zheng, Yanyan Chu, Qin Yin, Charles Yang, Wenyao Zhang, Yun Tang, Yi Yang. Crucial effect of the First CXXC Motif of Human QSOX 1b on the Activity to different substrates. Journal of Biochemistry. 2011, 149(3):293-300.

25. Wenyun Zheng, Yanyan Kang, Linfeng Li, Yuxin Xu, Xingyuan Ma, Levels of effectiveness of gene therapies targeting survivin and its splice variants in human breast cancer cells. Drug Discoveries & Therapeutics. 2011, 5(6):293-2989.  

鎺堟潈涓撳埄锛�

1.  鍙戞槑鍚嶇О锛氭姉PD-L1绾崇背鎶椾綋鍙婂叾搴旂敤锛屼笓鍒╂巿鏉冨彿锛�ZL202010808068.8

2.  鍙戞槑鍚嶇О锛氬熀浜庨波楸兼姉浣撳彲鍙樺尯V-NAR鐨勫櫖鑿屼綋鏂囧簱鍙婂叾鏋勫缓鏂规硶,涓撳埄鎺堟潈鍙凤細ZL202010808119.7

3.  鍙戞槑鍚嶇О锛氶澏鍚�TNF-伪鐨勪汉婧愬寲绾崇背鎶椾綋鍙婂叾鍒跺鍜岀敤閫旓紝涓撳埄鎺堟潈鍙凤細ZL202011297844.9

4.  鍙戞槑鍚嶇О锛氳礋杞�Survivin鍙屾姂鍒跺墏鐨勯搧铔嬬櫧绾崇背棰楃矑鍙婂叾鍒跺鏂规硶鍜屽簲鐢�, 涓撳埄鎺堟潈鍙�: ZL202010397566.8

5.  鍙戞槑鍚嶇О锛氭姂鍒�WSSV澧炴畺鐨勫崐鑳卞ぉ鍐皑閰搁叾鍩哄洜Cq-caspase鍙婂叾铔嬬櫧鎶楃梾姣掓椿鎬у簲鐢紝涓撳埄鎺堟潈鍙�:  ZL201811089877.7

6.  鍙戞槑鍚嶇О锛氱撼绫虫姉浣撻澏鍚戞€ф硾绱犲寲闄嶈В缁嗚優鍐呮簮鎬�Survivin缁勫悎鐗╁強鍏跺簲鐢紝涓撳埄鎺堟潈鍙凤細ZL202010421352.X

7. 鍙戞槑鍚嶇О: 涓€绉嶈偪鐦ゅ寲鐤楄嵂鐗╃殑铔嬬櫧澧炴晱鍓傦紝涓撳埄鎺堟潈鍙凤細 ZL201010608978.8

8.  鍙戞槑鍚嶇О锛氫竴绉嶅寮哄鑲借嵂鐗╀粠缁嗚優鍐呬綋閫冪鐨勮泲鐧借浇鑽郴缁熷強鍏跺簲鐢紱涓撳埄鎺堟潈鍙凤細ZL201310178357.4

9. 鍙戞槑鍚嶇О锛氫竴绉嶅唴鍚偨浠嬪鐨勭被寮规€ц泲鐧界函鍖栭噸缁勮泲鐧界殑鏂规硶锛屼笓鍒╂巿鏉冨彿锛�ZL201110236772.1

10. 鍙戞槑鍚嶇О锛氭潵鑷�LT浜氬熀鐨勭粏鑳炵┛鑶滆偨LTA2浣滀负缁嗚優鍐呰嵂鐗╄繍杈撹浇浣撶殑搴旂敤锛屼笓鍒╂巿鏉冨彿锛�ZL201410785006.4

11.  鍙戞槑鍚嶇О锛氫竴绉嶅熀浜庣粍鍚堣嚜鍓垏涓庤泲鐧芥敮鏋剁殑鐢熺墿娲绘€у皬鑲藉埗澶囨柟娉曪紝涓撳埄鎺堟潈鍙凤細ZL201611243905.7

璇氶個鎮ㄧ殑璁块棶鍜屽姞鐩�:鍚堜綔鍏辫耽锛�